FDA approves Pfizer’s COVID-19 vaccine for emergency use, US

FDA approves Pfizer’s COVID-19 vaccine for emergency use, US

Last updated:

Learn our story about how we are independent and what is needed to keep thisquality operating. You might be able to donate to us so we can inform and share what matters faster.

Learn Morearrow

The United States FDA (Food and Drug Administration) has approved the emergency use of Pfizer’s COVID-19 vaccine on Friday.

A 17-4 vote with one abstention was undertaken on Thursday, where the FDA Vaccines and Related Biological Products Advisory Committee acknowledged that the jab appears to be safe and effective for emergency use in people that are aged 16 and older.

Pfizer and a German company BioNTech developed the vaccine.


Critics say that the vaccine will be the first to fight against the COVID-19 virus in the United States after trials showed it was 95% effective in preventing such infection.

Image: Gettyimages

Have time to spare? If you liked this publication, please learn our story to support thisquality. Fund trustworthy news coming from official Government newswires and local voices inside communities.


COVID-19 Coverage

Alert Level 1: PREVENT
*All of New Zealand
*The button below directs to Government Unite Against COVID-19 website.

Notify of
Inline Feedbacks
View all comments